from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1916/aceAb

LFCtreatmentdescriptionclass of inhibitor

-3.152

Amikacinug/mL Amikacintranslation

-2.160

Cap5-10ug/mL Capreomycintranslation

-2.943

Rox10-50 ug/mL Roxithromycintranslation

-0.595

SM2-5 ug/mL Streptomycintranslation

-3.095

Tet5-10 ug/mL Tetracyclinetranslation

-1.031

Rif0.2-5ug/mL Rifampicintranscription

-0.312

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.264

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.134

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.299

CPZ10-50 ug/mL Chlorpromazinerespiration

0.877

Clofazimine10-13 ug/mL Clofaziminerespiration

0.927

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.453

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.474

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.215

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.003

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.601

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.545

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.273

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.657

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.448

KCN5-20 ug/mL Potassium cyaniderespiration

1.420

NaN30.2-2 mM Sodium aziderespiration

0.380

Nigericin50 uM Nigericinrespiration

0.234

TRC10-150 ug/mL Triclosanrespiration

0.742

TRZ10-25 ug/mL Thioridazinerespiration

-2.402

Valinomycin0.5-10 uM Valinomycinrespiration

1.337

ZnSO42 mM ZnSO4respiration

0.381

menadione6-10 ug/mL Menadionerespiration

-0.219

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.122

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.356

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.010

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.309

NRP_1Non-replicating persistence stage 1dosRassociated

-0.004

Amp0.2mg/mL AmpicillincellWall

-0.177

Cephalexin20-100 ug/mL CephalexincellWall

-0.423

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.082

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.387

EMB10-20 ug/mL EthambutolcellWall

-0.310

Eta12-40 ug/mL EthionamidecellWall

-0.549

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.366

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.278

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.374

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.506

BZA0.12 mg/mL BenzamidearomaticAmides

0.072

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.033

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.371

H2O24 mM hydrogen peroxideDNAdamaging

0.221

Levo10 ug/mL LevofloxacinDNAdamaging

-0.118

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.132

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.706

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.375

UVUV-irradiationDNAdamaging

-0.538

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.052

Antimycin12.5-50 ug/mL Antimycin A?

-0.012

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.647

PA_110-50 ug/mL Antitubercular compound PA-1?

0.407

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.035

PA8240.2-2 ug/mL PA-824?

0.175

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.144

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.093

Verapamil50 uM Verapamil?

0.329

mercaptoethanol2 mM 2-Mercaptoethanol?

0.238

methoxatin10-20 ug/mL Methoxatin?